Melior Discovery Awarded SBIR Grant for Studying MLR-1023 Mechanism of Action

By WebmasterDecember 11, 2014November 1st, 2024No Comments

Melior Discovery Awarded SBIR Grant for Studying MLR-1023 Mechanism of Action
Read more here

Previous PostOssianix Expands and Extends its Research Collaboration with Lundbeck on CNS Therapeutics
Next PostRelmada Therapeutics Receives Health Canada Clearance to Commence First Clinical Study of d-Methadone